Immunosuppression and atypical infections in CML patients treated with dasatinib at 140 mg daily
Year: 2009
Type: article
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2152024997
